1338 Automated Volumetric Segmentation Enables Post-Laser Interstitial Thermal Therapy Response Assessment

INTRODUCTION: Laser interstitial thermal therapy (LITT) allows for confirmatory tissue diagnosis, surgical cytoreduction, and faster return to systemic therapies for patients with brain tumors or radiation necrosis. Ablated tissue remains in situ following LITT, with post-LITT edema potentially associated with transient clinical worsening and complicating subsequent response assessment. METHODS: All patients receiving LITT at a single center for tumors or radiation necrosis from 2015 – 2023 with = 9 months of MRI follow-up were retrospectively reviewed. A 3D U-net segmentation model implemented in nnU-Net was developed for automated segmentation of Contrast-enhancing Lesion Volume (CeLV) of LITT-treated lesions on T1-weighted post-contrast MR images. CeLVs were analyzed to perform volumetric post-LITT response assessments. RESULTS: Sixty-one LITT-treated lesions and 6 control cases of medically-managed radiation necrosis were analyzed across 384 unique MRI exams. Automated segmentation was qualitatively accurate in 367/384 (95.6%) images. CeLV increased to a median of 68.3% (IQR 35.1 – 109.2%) from baseline at 1 – 3 months from LITT (P = 0.0012) and returned to baseline thereafter. Median overall survival (mOS) for LITT-treated patients was 39.1 (9.2 – 93.4) months. In accordance with previously established volumetric thresholds, volumetric disease progression was defined as CeLV increase = 40% from volumetric nadir or baseline. Twenty-one of 56 (37.5%) patients experienced volumetric progression with a progression-free survival of 21.4 (6.0 – 93.4) months. Volumetric progression was associated with lower mOS (17.3 vs 62.1 months, P = 0.0015). CONCLUSIONS: CeLV increased to nearly 70% from baseline at 1 - 3 months following LITT, resolving within 3 - 6 months of the procedure. To facilitate inclusion of LITT patients in clinical trials, we developed and demonstrated feasibility of response assessment criteria to account for this transient post-ablation CeLV expansion. Automated lesion segmentation may increase the rate of adoption for volumetric response assessment in clinical practice.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_1338
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1338 Automated Volumetric Segmentation Enables Post-Laser Interstitial Thermal Therapy Response Assessment

James E. Herndon, Peter E. Fecci, Evan Calabrese, Aden Haskell-Mendoza et al.
Neurosurgery
Radiomics and Machine Learning in Medical Imaging
article

1338 Automated Volumetric Segmentation Enables Post-Laser Interstitial Thermal Therapy Response Assessment

James E. Herndon, Peter E. Fecci, Evan Calabrese, Aden Haskell-Mendoza, Eric W. Sankey, Joshua Jackson, Elle Reason, Ethan Srinivasan, Ariel Tomas Gonzalez
article en

Abstract

INTRODUCTION: Laser interstitial thermal therapy (LITT) allows for confirmatory tissue diagnosis, surgical cytoreduction, and faster return to systemic therapies for patients with brain tumors or radiation necrosis. Ablated tissue remains in situ following LITT, with post-LITT edema potentially associated with transient clinical worsening and complicating subsequent response assessment. METHODS: All patients receiving LITT at a single center for tumors or radiation necrosis from 2015 – 2023 with = 9 months of MRI follow-up were retrospectively reviewed. A 3D U-net segmentation model implemented in nnU-Net was developed for automated segmentation of Contrast-enhancing Lesion Volume (CeLV) of LITT-treated lesions on T1-weighted post-contrast MR images. CeLVs were analyzed to perform volumetric post-LITT response assessments. RESULTS: Sixty-one LITT-treated lesions and 6 control cases of medically-managed radiation necrosis were analyzed across 384 unique MRI exams. Automated segmentation was qualitatively accurate in 367/384 (95.6%) images. CeLV increased to a median of 68.3% (IQR 35.1 – 109.2%) from baseline at 1 – 3 months from LITT (P = 0.0012) and returned to baseline thereafter. Median overall survival (mOS) for LITT-treated patients was 39.1 (9.2 – 93.4) months. In accordance with previously established volumetric thresholds, volumetric disease progression was defined as CeLV increase = 40% from volumetric nadir or baseline. Twenty-one of 56 (37.5%) patients experienced volumetric progression with a progression-free survival of 21.4 (6.0 – 93.4) months. Volumetric progression was associated with lower mOS (17.3 vs 62.1 months, P = 0.0015). CONCLUSIONS: CeLV increased to nearly 70% from baseline at 1 - 3 months following LITT, resolving within 3 - 6 months of the procedure. To facilitate inclusion of LITT patients in clinical trials, we developed and demonstrated feasibility of response assessment criteria to account for this transient post-ablation CeLV expansion. Automated lesion segmentation may increase the rate of adoption for volumetric response assessment in clinical practice.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 93%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.